Cargando…

Genetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver disease

Metabolic associated fatty liver disease (MAFLD) is the most prevalent liver disease in Western nations, with high heritability. A recent study of Japanese patients with the disease suggested that TLL1 rs17047200 is associated with fibrosis; whether a similar association is observed in Caucasian pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bayoumi, Ali, Jalil, Ismail, Metwally, Mayada, Adams, Leon A., Aller, Rocio, García-Monzón, Carmelo, Arias-Loste, María Teresa, Miele, Luca, Petta, Salvatore, Craxì, Antonio, Gallego-Durán, Rocio, Fischer, Janett, Berg, Thomas, Qiao, Liang, Liddle, Christopher, Bugianesi, Elisabetta, Romero-Gomez, Manuel, George, Jacob, Eslam, Mohammed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732106/ https://www.ncbi.nlm.nih.gov/pubmed/33306709 http://dx.doi.org/10.1371/journal.pone.0243590

Ejemplares similares

Mistranslation Drives Alterations in Protein Levels and the Effects of a Synonymous Variant at the Fibroblast Growth Factor 21 Locus
por: Bayoumi, Ali, et al.
Publicado: (2021)

Copy number variation and expression of exportin-4 associates with severity of fibrosis in metabolic associated fatty liver disease
por: Metwally, Mayada, et al.
Publicado: (2021)

PNPLA3 and TLL-1 Polymorphisms as Potential Predictors of Disease Severity in Patients With COVID-19
por: Grimaudo, Stefania, et al.
Publicado: (2021)

A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms
por: Sharkawy, Rasha El, et al.
Publicado: (2019)

Novel and Highly Efficient Regioselective Route to Helicid Esters by Lipozyme TLL
por: Yang, Rongling, et al.
Publicado: (2013)

Graphene-TLL-Cu(2)ONPs Hybrid as Highly Efficient Catalyst for Degradation of Organic Compounds
por: Losada-Garcia, Noelia, et al.
Publicado: (2023)

Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Petta, Salvatore, et al.
Publicado: (2014)

Structural and functional evidence for a substrate exclusion mechanism in mammalian tolloid like-1 (TLL-1) proteinase
por: Berry, Richard, et al.
Publicado: (2010)

Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease
por: Pelusi, Serena, et al.
Publicado: (2016)

Ant Lion Optimization algorithm for kidney exchanges
por: Hamouda, Eslam, et al.
Publicado: (2018)

Possible Relevance of PNPLA3 and TLL1 Gene Polymorphisms to the Efficacy of PEG-IFN Therapy for HBV-Infected Patients
por: Enomoto, Hirayuki, et al.
Publicado: (2020)

IFNL3 genotype is associated with pulmonary fibrosis in patients with systemic sclerosis
por: Metwally, Mayada, et al.
Publicado: (2019)

Consumer Knowledge, Perceptions, Attitudes and Practices on the Use of Nutrition Labeling including Traffic Light Labeling (TLL) System in Sri Lanka
por: Perera, Thushanthi, et al.
Publicado: (2022)

Plant growth promotion under phosphate deficiency and improved phosphate acquisition by new fungal strain, Penicillium olsonii TLL1
por: Suraby, Erinjery Jose, et al.
Publicado: (2023)

IFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infection
por: O'Connor, K S, et al.
Publicado: (2016)

Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation
por: Gallego-Durán, Rocío, et al.
Publicado: (2022)

Pathophysiology of Non Alcoholic Fatty Liver Disease
por: Petta, Salvatore, et al.
Publicado: (2016)

Therapeutic algorithms for chronic hepatitis C in the DAA era during the current economic crisis: whom to treat? How to treat? When to treat?
por: Petta, Salvatore, et al.
Publicado: (2012)

Association between Interferon-Lambda-3 rs12979860, TLL1 rs17047200 and DDR1 rs4618569 Variant Polymorphisms with the Course and Outcome of SARS-CoV-2 Patients
por: Agwa, Sara H. A., et al.
Publicado: (2021)

Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease
por: Gallego-Durán, Rocío, et al.
Publicado: (2016)

Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool
por: Marañón, Patricia, et al.
Publicado: (2022)

Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis
por: Turola, Elena, et al.
Publicado: (2015)

Association of the APOA-5 Genetic Variant rs662799 with Metabolic Changes after an Intervention for 9 Months with a Low-Calorie Diet with a Mediterranean Profile
por: de Luis Roman, Daniel, et al.
Publicado: (2022)

Nutrition and Chronic Liver Disease
por: Aller de la Fuente, Rocío
Publicado: (2022)

Circulating bone morphogenetic protein 8A is a novel biomarker to predict advanced liver fibrosis
por: Marañón, Patricia, et al.
Publicado: (2023)

A metabolic associated fatty liver disease risk variant in MBOAT7 regulates toll like receptor induced outcomes
por: Alharthi, Jawaher, et al.
Publicado: (2022)

Genomic analysis of a spinal muscular atrophy (SMA) discordant family identifies a novel mutation in TLL2, an activator of growth differentiation factor 8 (myostatin): a case report
por: Jiang, Jianping, et al.
Publicado: (2019)

Effectiveness of neuromuscular electrostimulation in COPD subjects on mechanical ventilation. A systematic review and meta-analysis
por: Gutiérrez-Arias, Ruvistay, et al.
Publicado: (2022)

Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD)
por: Del Campo, José A, et al.
Publicado: (2018)

Association of Common Polymorphisms in the Interleukin-1 Beta Gene with Hepatocellular Carcinoma in Caucasian Patients with Chronic Hepatitis B
por: Fischer, Janett, et al.
Publicado: (2022)

A Pilot Study of Gene Expression Analysis in Peripheral Blood Mononuclear Cells in Response to a Hypocaloric Mediterranean Diet
por: de Luis, Daniel, et al.
Publicado: (2022)

A Randomized Trial with Two Hypocaloric Diets with Different Lipid Profiles and Effects on Serum Omentin-1 Levels in Obese Subjects
por: de Luis, Daniel, et al.
Publicado: (2022)

Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology
por: Calleja, José L., et al.
Publicado: (2022)

Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity
por: Lamadrid, Patricia, et al.
Publicado: (2021)

Systematic review and meta-analysis: analysis of variables influencing the interpretation of clinical trial results in NAFLD
por: Ampuero, Javier, et al.
Publicado: (2022)

Experimental obstructive cholestasis: the wound-like inflammatory liver response
por: Aller, María-Angeles, et al.
Publicado: (2008)

MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C
por: Thabet, Khaled, et al.
Publicado: (2016)

Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases
por: Gallego-Durán, Rocío, et al.
Publicado: (2021)

Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores
por: Bianco, Cristiana, et al.
Publicado: (2021)

Hepatitis B Virus-Associated Hepatocellular Carcinoma
por: Rizzo, Giacomo Emanuele Maria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_njfhfc66lirqpgl8sdmr3jf60u